Loading...
  • Agents
  • In the past, antimetabolites (e.g., cytarabine, hydroxyurea), alkylating agents, interferon alfa 2b, and steroids were used as treatments of CML in the chronic phase, but since the 2000s have been replaced by Bcr-Abl tyrosine-kinase inhibitors drugs that specifically target BCR-ABL, the constitutively activated tyrosine kinase fusion protein caused by the Philadelphia chromosome translocation. (wikipedia.org)
  • Study
  • The purpose of this study is to evaluate the safety and efficacy of co-administration of ABT-450 (also known as paritaprevir) with ritonavir (ABT-450/r) and ABT-267 (also known as ombitasvir) in adults with chronic hepatitis C virus infection. (clinicaltrials.gov)
  • cancers
  • The branch of Medical Oncology within the majority of the analysis centres, hospitals, institutes has master advisors with enthusiasm for the administration of solid tumours and in addition paediatric cancers. (soaoj.com)
  • intravenous
  • It is a sterile, nonpyrogenic, aqueous solution of clear and colorless to light pink appearance in clear glass multidose vials for intravenous administration. (healthbiotechlimited.com)
  • Some effects are dependent upon the route of administration, with intravenous use associated with the transmission of many disease such as Hepatitis C , HIV/AIDS and potential medical emergencies such as infection , thrombosis or pseudoaneurysm , while inhalation may be associated with increased lower respiratory tract infection , lung cancer , and pathological restricting of lung tissue. (thcscience.wiki)
  • patients
  • ONS's position is that nurses who care for patients receiving immunotherapy agents are determined by their respective practice sites to be competent in immunotherapy administration after receiving a fundamental knowledge of principles such as mechanism of action, side effects and management, safe handling, administration considerations, and others. (ons.org)
  • drug
  • Und durchfall ixempra is xeloda the same as 5 fu 500 mg precio en mexico warfarin interaction.Xeloda is an approved oral drug developed by F. Hoffmann-La Roche. (babyfootpeel.tk)